NNNN

Anbio Biotechnology develops commercial-stage in vitro diagnostic products across infectious diseases, cancer, cardiovascular disease, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes using established IVD technology platforms. The company collaborates with third-party laboratories for biomarker discovery, assay development, and validation, then outsources manufacturing while retaining sales and profits, with all products currently CE marked and ready for commercialization in the European Union and distributed across the EU, Asia Pacific, Americas, and Africa.

Pipeline

Catalyst Calendar